Image: dietpillsthatwork.co.uk
The MHRA has told doctors to stop prescribing leading obesity drug, REDUCTIL [SIBUTRAMINE] amid fears it raises risk of heart attacks and strokes.
The BBC reports that the MHRA acted after a review by the European Medicines Agency (EMA) recommended suspending its licence in Europe.
It's a head scratching moment, for me at least.
The total number of reported fatal adverse drug reactions for Reductil currently stands at 17. There have been a total of 1,104 adverse drug reactions to Reductil. [Fig 1]
Fig 1
CLICK ON IMAGE TO ENLARGE
Meantime, there has been a total number of 169 fatal adverse drug reactions to Seroxat, that's a staggering 152 more than Reductil. Furthermore, there has been a total of 10,432 adverse drugs reactions reported to the MHRA regarding Seroxat, some 9,328 more than Reductil. [Fig 2]
Fig 2
CLICK ON IMAGE TO ENLARGE
Another example would be Eli Lily's, Prozac. The MHRA have received a total number of 226 fatal ADR reports and a mind blowing 9,106 number of non-fatal ADR reports. [Fig 3]
Fig 3
CLICK ON IMAGE TO ENLARGE
Even the SNRi, Efexor, has far more fatal ADR reports [149] than Reductil. [Fig 4]
Fig 4
CLICK ON IMAGE TO ENLARGE
Just how many more fatal reports for antidepressants do the MHRA need to convince them that these specific types of drugs have more risks than benefits?
Now, who was it that once said, "The evidence, however, is clear"?
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
3 comments: